Cardiovascular Events
Also known as: Cardiovascular Event / Cardiac Event / Cardiac Events / Cardiovascular event (event)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00945 | Acetylsalicylic acid | A salicylate used to treat pain, fever, inflammation, migraines, and reducing the risk of major adverse cardiovascular events. |
| DB00381 | Amlodipine | A calcium channel blocker used to treat hypertension and angina. |
| DB00612 | Bisoprolol | A beta-1 adrenergic blocking agent used to prevent myocardial infarction and heart failure and to treat mild to moderate hypertension. |
| DB08907 | Canagliflozin | A sodium-glucose co-transporter 2 (SGLT2) inhibitor used to manage hyperglycemia in type 2 diabetes mellitus (DM). Also used to reduce the risk of major cardiovascular events in patients with established cardiovascular disease and type 2 DM. |
| DB00758 | Clopidogrel | An antiplatelet agent used to prevent blood clots in peripheral vascular disease, coronary artery disease, and cerebrovascular disease. |
| DB06779 | Dalteparin | A low molecular weight heparin used for the prophylaxis of thrombotic events in certain patients and prevent acute cardiac ischemic events in patients with unstable angina and non-Q-wave myocardial infarction. |
| DB00722 | Lisinopril | An ACE inhibitor used to treat hypertension, heart failure, and acute myocardial infarction. |
| DB06209 | Prasugrel | A P2Y12 platelet inhibitor used to reduce risk of thrombotic cardiovascular events in unstable angina or non-ST-elevation myocardial infarction (NSTEMI), and in patients with STEMI when managed with either primary or delayed PCI. |
| DB00178 | Ramipril | An ACE inhibitor used for the management of hypertension and the reduction of cardiovascular mortality following myocardial infarction in hemodynamically stable patients with clinical signs of congestive heart failure. |
| DB01098 | Rosuvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular disease including myocardial infarction and stroke. |
| DB09292 | Sacubitril | A neprilysin inhibitor used in combination with valsartan as an adjunct to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. |
| DB00641 | Simvastatin | An HMG-CoA reductase inhibitor used to lower lipid levels and reduce the risk of cardiovascular events including myocardial infarction and stroke. |
| DB00966 | Telmisartan | An ARB used to treat hypertension, diabetic nephropathy, and congestive heart failure. |
| DB00775 | Tirofiban | A platelet aggregation inhibitor used to prevent thrombotic events in non-ST elevated acute coronary syndrome. |
| DB09030 | Vorapaxar | A platelet aggregation inhibitor used to reduce thrombotic cardiovascular events in patients with a history of myocardial infarction (MI) or peripheral arterial disease (PAD). |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06699 | Degarelix | 2 | Not Yet Recruiting | 1 |
| DB00644 | Gonadorelin | 2 | Not Yet Recruiting | 1 |
| DB13453 | Xenon | 2 | Not Yet Recruiting | 1 |
| DB09026 | Aliskiren | 3 | Terminated | 1 |
| DB00381 | Amlodipine | 3 | Terminated | 1 |
| DB00999 | Hydrochlorothiazide | 3 | Terminated | 1 |
| DB01373 | Calcium | 4 | Completed | 1 |
| DB00258 | Calcium acetate | 4 | Completed | 1 |
| DB06724 | Calcium carbonate | 4 | Completed | 1 |
| DB01184 | Domperidone | 4 | Unknown Status | 1 |
| DB00448 | Lansoprazole | 4 | Unknown Status | 1 |
| DB00922 | Levosimendan | 4 | Recruiting | 1 |
| DB00658 | Sevelamer | 4 | Completed | 1 |
| DB11842 | Angiotensin II | Not Available | Not Yet Recruiting | 1 |
| DB01112 | Cefuroxime | Not Available | Withdrawn | 1 |
| DB01235 | Levodopa | Not Available | Completed | 1 |